CRISPR therapeutics can damage the genome, researchers warn
A new study identifies risks in the use of CRISPR therapeutics — an innovative, Nobel-prize-winning method that involves cleaving and editing DNA, already employed for the treatment of conditions like cancer, liver and intestinal diseases, and genetic syndromes.
Materials provided by Tel-Aviv University. Note: Content may be edited for style and length.
Source link aaaaa